Pharmaceutical Programme Development in SADC Region
Southern African Development Community (SADC) comprises of 15 member states of Southern African region. SADC started the harmonization of policies and guidelines in 1992 through pharmaceutical programme for easily access to affordable and safe effective medicines. In SADC region major disease like AIDS, Ebola, Malaria and other blood related diseases are transforming to serious threat for public domain. SADC is concerned to cure and prevent these diseases, which is a major threat to public health of this region. In recent scenario generic medicines are overtaking the global pharmaceutical market as these drugs are easily available at affordable price. In this decade SADC has initiated health programmes based on the use of generic medicines, which are quite efficient for public domain and also for this organisation. SADC is also partner with ICH and WHO for development of policies and guidelines to provide effective and good quality of medicines. To acquire this goal SADC have developed and approved the 15 guidelines, which is mentioned in this article. The present article focuses on the pharmaceutical program development in SADC. The main objective of the present article is to describe in detail about the SADC organization and its structure and development of the harmonization guidelines by SADC through pharmaceutical programmes.